Actinium Pharmaceuticals
ATNM
#10394
Rank
โ‚น4.22 B
Marketcap
โ‚น134.32
Share price
10.00%
Change (1 day)
13.94%
Change (1 year)

Operating Margin for Actinium Pharmaceuticals (ATNM)

Operating Margin as of November 2026 (TTM): 4.91%

According to Actinium Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 4.91%. At the end of 2021 the company had an Operating Margin of -2,165.56%.

Operating Margin history for Actinium Pharmaceuticals from 2021 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-2,165.56%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Genocea Biosciences
GNCA
-1,084.89%-22,195.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
0.03%-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
4.37%-11.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.